Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00105
|
|||||
| Drug Name |
S-adenosylmethionine
|
|||||
| Synonyms |
29908-03-0; 6EZ5466ZUX; Active methionine; Adenosine, 5'-((3-amino-3-carboxypropyl)methylsulfonio)-5'-deoxy-, inner salt, (3S)-; AdoMet; CCRIS 7130; CHEBI:67040; EINECS 249-946-8; K093C397UL; L-Methionine, S-adenosyl-; L-S-Adenosylmethionine; Methionine, S-adenosyl-; Methioninyladenylate; S Amet; S-adenosyl-L-methioninate; S-adenosyl-L-methionine; SAM; UNII-6EZ5466ZUX; UNII-7LP2MPO46S; UNII-K093C397UL; adenosylmethionine; s-(5-adenosyl)l-methionine
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Alcoholic liver disease [ICD11: DB94] | Phase 3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H22N6O5S
|
|||||
| Canonical SMILES |
C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O
|
|||||
| InChI |
InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27?/m0/s1
|
|||||
| InChIKey |
MEFKEPWMEQBLKI-AIRLBKTGSA-N
|
|||||
| CAS Number |
CAS 29908-03-0
|
|||||
| Pharmaceutical Properties | Molecular Weight | 398.4 | Topological Polar Surface Area | 187 | ||
| Heavy Atom Count | 27 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 10 | |||
| XLogP |
-2.8
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:67040
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | SAMC | Transporter Info | S-adenosylmethionine mitochondrial carrier protein | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT00573313) Effects of SAMe in Patients With Alcoholic Liver Disease | |||||
| 2 | FOXD3 acts as a repressor of the mitochondrial S-adenosylmethionine carrier (SLC25A26) gene expression in cancer cells. Biochimie. 2018 Nov;154:25-34. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.